Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

BACKGROUND: No biomarker exists to guide the optimal choice of chemotherapy for patients with metastatic colorectal cancer. We examined the copy numbers (CN) of topoisomerase I (TOP1) as well as the ratios of TOP1/CEN-20 and TOP1/CEN-2 as biomarkers for irinotecan efficacy in patients with metastati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Palshof, Jesper Andreas, Høgdall, Estrid Vilma Solyom, Poulsen, Tim Svenstrup, Linnemann, Dorte, Jensen, Benny Vittrup, Pfeiffer, Per, Tarpgaard, Line Schmidt, Brünner, Nils, Stenvang, Jan, Yilmaz, Mette, Nielsen, Dorte Lisbet
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225543/
https://ncbi.nlm.nih.gov/pubmed/28077117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-3001-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky